CJC-1295 – With DAC 10mg

CJC-1295 (10mg) is studied in peptide research focused on modified peptide signaling. Peptide signaling refers to the way short amino acid chains interact with cellular receptors in experimental systems.

Laboratories in the United States examine cjc-1295 (10mg) in controlled biochemical environments. These investigations are non-clinical.

CJC-1295 (10mg) is not a prescription compound. It is not distributed through order pharmacy channels. A doctor does not issue a prescription for cjc-1295 (10mg) within research frameworks.

This compound is not designed for patient treatment. It is not associated with health management programs. It is not developed for blood sugar treatment models or pain-related protocols.

CJC-1295 (10mg) has been investigated in research settings analyzing modified peptide stability and receptor interaction models. Receptor interaction refers to the binding of a molecule to a specific cellular site.

Some experimental studies explore peptide structure in relation to metabolic markers such as blood sugar measurement systems. Blood sugar refers to glucose concentration evaluated in laboratory samples.

Researchers may evaluate molecular pathways connected to systemic health markers. Health markers are measurable biological indicators observed in controlled models.

These studies do not imply treatment outcomes. CJC-1295 (10mg) is not intended for prescription use or doctor-supervised treatment programs.

Taking cjc-1295 (10mg) outside controlled laboratory settings is not within its defined scope. Starting experimental procedures requires institutional approval and documentation.

CJC-1295 (10mg) is intended for laboratory handling only. Standard laboratory safety protocols should be followed when taking research materials into controlled environments.

Store cjc-1295 (10mg) in a dry and temperature-controlled setting. Controlled storage helps preserve peptide purity and molecular stability.

Avoid exposure to moisture and direct light. Proper storage conditions support consistent evaluation during research cycles.

CJC-1295 (10mg) is not available through prescription distribution systems. A doctor cannot provide a prescription for cjc-1295 (10mg) in research supply channels.

It is not developed for patient treatment or health intervention. It is not part of blood sugar treatment programs. It is not associated with pain management pathways.

Each batch of cjc-1295 (10mg) undergoes analytical verification procedures. High-performance liquid chromatography confirms peptide purity. High-performance liquid chromatography is a method used to separate and measure compound components.

Mass spectrometry validates molecular weight and structural identity. Mass spectrometry identifies molecules based on mass-to-charge ratio.

Quality control testing cjc-1295 (10mg) ensures batch consistency across production lots. Documentation accompanies each research peptide supply shipment.

Every size and unit is inspected prior to release to confirm labeling accuracy and structural verification.

• CAS: 863288-34-0
• Chemical Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3648.4 g/mol
• Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Malimide-beta-Ala)-NH2
• Synonyms: CJC1295, CJC-1295 with DAC
• Shelf life: 24 months from the manufacturing date.

CJC-1295 (10mg) peptide is a synthetic analog of growth hormone-releasing hormone. An analog is a compound designed to resemble another molecule while maintaining structural differences.

The DAC modification is covalently attached. Covalent attachment means atoms share electrons to create a stable chemical bond.

CJC-1295 (10mg) peptide contains a defined amino acid sequence. Amino acids are small organic molecules that form peptides and proteins.

This structure is engineered to maintain molecular stability under proper storage conditions. No added sugar or filler compounds are present in the verified analytical profile.

Research-Grade Purity

CJC-1295 (10mg) is produced to meet strict peptide purity specifications. Peptide purity refers to the percentage of the intended molecular structure present within a batch. Analytical testing confirms identity and structural integrity.

Modified Peptide with DAC Component

CJC-1295 (10mg) includes a DAC modification. DAC stands for Drug Affinity Complex. This modification is a chemical attachment that alters molecular binding characteristics during experimental evaluation.

The modified structure of cjc-1295 (10mg) supports extended stability in laboratory models.

Designed for Laboratory Workflows

CJC-1295 (10mg) is packaged in a standardized pack size for structured research documentation. Each size and unit is clearly labeled for tracking within research peptide supply systems.